Instil Bio (TIL) Total Current Liabilities (2020 - 2026)

Instil Bio has reported Total Current Liabilities for 7 years, with the latest figure at $3.3 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities fell 76.14% year-over-year to $3.3 million in Q2 2026; TTM through Jun 2026 was $3.3 million, a 76.14% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 38.67% from the prior year.
• Total Current Liabilities was $3.3 million for Q2 2026 at Instil Bio, down from $4.7 million in the prior quarter.
• The five-year high for Total Current Liabilities was $43.2 million in Q2 2022, with the low at $3.3 million in Q2 2026.
• Average Total Current Liabilities over 5 years is $16.9 million, with a median of $11.0 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Total Current Liabilities soared 112.28% in 2022, then slumped 76.14% in 2026.
• Over 5 years, Total Current Liabilities stood at $32.8 million in 2022, then slumped by 67.8% to $10.6 million in 2023, then slipped by 25.22% to $7.9 million in 2024, then slumped by 38.67% to $4.8 million in 2025, then tumbled by 31.76% to $3.3 million in 2026.
• The last three Total Current Liabilities figures came in at $3.3 million (Q2 2026), $4.7 million (Q1 2026), and $4.8 million (Q4 2025), per Business Quant data.